The present invention relates to 2-aminoquinolines of formula I
wherein R
1
, R
2
and R
3
are as defined in the specification, as 5-HT
5A
receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use for the treatment of CNS disorders.
本发明涉及公式I中的
2-氨基喹啉,其中R1,R2和R3如规范中定义的5-HT5A受体拮抗剂,它们的制造,含有它们的制药组合物以及它们用于治疗中枢神经系统疾病的用途。